Juan Jesús
Cruz Hernández
Profesor Emérito
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (7)
2017
-
A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients
Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357
2015
-
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
Genome Biology, Vol. 16, Núm. 1
2010
-
Cancer as a reprogramming-like disease: Implications in tumor development and treatment
Seminars in Cancer Biology, Vol. 20, Núm. 2, pp. 93-97
2007
-
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663
2006
-
BRCA1-2 mutations in breast cancer: Identification of nine new variants of BRCA1-2 genes in a population from central Western Spain
Cancer Letters, Vol. 233, Núm. 1, pp. 172-177
-
Trastuzumab and antiestrogen therapy: Focus on mechanisms of action and resistance
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 29, Núm. 1, pp. 90-95
2003
-
Her-2/neu Gene Amplification in Familial vs Sporadic Breast Cancer: Impact on the Behavior of the Disease
American Journal of Clinical Pathology, Vol. 120, Núm. 6, pp. 917-927